Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2023-09-01
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-dose Contrast Media for Low-kVp Abdomen CT
NCT05878665
The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia
NCT06445660
Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight.
NCT03735706
Uniformity of Oral Contrast Material in the Bowel
NCT02542046
Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
NCT00478556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If immediate surgery is needed- it will not be delayed If patients are eligible for conservative management- they will be randomized to 2 study groups- contrast media (CM) after 4 hours of nasogastric-tube decompression and after 24 hours of nasogastric-tube decompression.
Contrast media challenge acquires radiographs (X-rays) to be taken after an interval (common practice) decided by the surgeon.
If at any point patient needs surgery- it will not be delayed. The results are compared. The hypothesis is, that if CM is administered sooner- it will help SBO resolution
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contrast media 4 hours
Patients will receive contrast media after 4 hours of nasogastric decompression
Effect on contrast media depending on the time of its administratsion
CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered
Contrast media 24 hours
Patients will receive contrast media after 24 hours of nasogastric decompression
Effect on contrast media depending on the time of its administratsion
CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Effect on contrast media depending on the time of its administratsion
CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation
* No peritonitis present, no need for an emergent surgery
* Patients sign an informed consent
Exclusion Criteria
* Patients with mechanical small bowel obstruction caused by incarcerated hernias
* Patients with mechanical small bowel obstruction caused by carcinomatosis
* Patients with paralytic small bowel obstruction
* Patients who have undergone surgery within 6 weeks
* Patients who do not want to be enrolled in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
North Estonia Medical Centre
OTHER
University of Tartu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liis Jaanimäe
General Surgeon, PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liis Jaanimäe
Role: PRINCIPAL_INVESTIGATOR
University of Tartu
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tartu University Hospital
Tartu, Tartu, Estonia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.